THE CHINWAGY BUZZ · FIRST VERIFIED WORD
Sinopharm-CNBG and G42 joint venture Hayat Biotech supplies influenza vaccine to UAE

WHAT CHINWAGY KNOWS
The collaboration
is confirmed.
A quadrivalent influenza vaccine developed by a Sinopharm CNBG subsidiary won a UAE purchase bid through Hayat Biotech, the CNBG-G42 joint venture, following UAE regulatory approval.
- Current status
- Official collaboration
- Known availability
- Started 2024-05-03; the official source does not state an end date.
- Place
- International, United Arab Emirates
- Source checked
- September 12, 2026
FOLLOW THE STORY